Asia-Pacific markets climb after massive rally on Wall Street on U.S.-China trade deal

Asia-Pacific markets climb after massive rally on Wall Street on U.S.-China trade deal


This photo was shot from Varanasi, India in the morning. The soft sun light touch the old building along the ganga river. “n”nVaranasi is a North Indian city on the banks of the Ganges in Uttar Pradesh. It is one of the oldest continuously inhabited cities in the world. The spiritual capital of India, it is the holiest of the seven sacred cities in Hinduism and Jainism, and played an important role in the development of Buddhism.

Photographed By Mr.anujak Jaimook | Moment | Getty Images

Asia-Pacific markets climbed Tuesday, following a massive rally on Wall Street after the U.S. and China agreed to a trade deal.

Japan’s benchmark Nikkei 225 surged 2.17% at the open, while the broader Topix index advanced 1.77%.

In South Korea, the Kospi index moved up 0.13% while the small-cap Kosdaq added 1.01% in early trade.

Australia’s S&P/ASX 200 rose 0.71%.

Futures for Hong Kong’s Hang Seng index stood at 23,403, pointing to a weaker open compared to the HSI’s last close of 23,549.46.

Investors will be paying close attention to Indian markets, which surged Monday on optimism over the India—Pakistan ceasefire. The benchmark Nifty 50 ended the day at 24,924.70, its highest level since Oct. 16, 2024, while the BSE Sensex index closed at 82,429.90, its highest since Oct. 3, 2024.

U.S. stock futures were flat after all three key benchmarks hit their best day since April 9, as investors awaited the release of an inflation report.

Overnight stateside, stocks soared as investors’ fears of a recession in the U.S., sparked by a trade war with China, were abated after the two superpowers arrived at a deal.

The Dow Jones Industrial Average surged 1,160.72 points, or 2.81%, and closed at 42,410.10. The 30-stock index ended the session near its highs of the day, with buying enthusiasm remaining strong.

Meanwhile, the broad-based S&P 500 popped 3.26% to end at 5,844.19, giving it gains of over 20% since its April intraday low at the height of tariff pessimism. The benchmark’s year-to-date losses have now narrowed to just 0.6%.

The Nasdaq Composite added 4.35% and settled at 18,708.34, as the details of the trade deal sent technology stocks with exposure to China — like Tesla and Apple — higher.

— CNBC’s Brian Evans, Yun Li and Fred Imbert contributed to this report.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More